Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Plos One|October 4, 2016
Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group StudyFlora Stavridi, Konstantine T Kalogeras, Kyriaki Pliarchopoulou, et al.Oncotarget|April 30, 2016
TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant settingGeorge Fountzilas, Eleni Giannoulatou, Zoi Alexopoulou, et al.Plos One|August 11, 2017
Protein expression patterns of cell cycle regulators in operable breast cancerFlora Zagouri, Vassiliki Kotoula, George Kouvatseas, et al.Virchows Archiv : an International Journal of Pathology|October 12, 2012
Serrated polyps of the colon: how reproducible is their classification?Arzu Ensari, Banu Bilezikçi, Fatima Carneiro, et al.Journal of Translational Medicine|February 15, 2017
Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology GroupAmanda Psyrri, Konstantine T Kalogeras, Ralph M Wirtz, et al.Oncology Letters|December 6, 2021
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumabVassiliki Rapti, Evangelia Moirogiorgou, Georgia-Angeliki Koliou, et al.Cancer Immunology, Immunotherapy : CII|April 19, 2020
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?Triantafyllia Koletsa, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.Plos One|August 1, 2018
Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trialAnna Goussia, Nafsika Simou, Flora Zagouri, et al.Breast (Edinburgh, Scotland)|January 4, 2024
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytesFoteinos-Ioannis Dimitrakopoulos, Anna Goussia, Georgia-Angeliki Koliou, et al.Obesity Surgery|June 13, 2024
Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND StudyAlessandro Martinino, Kushan D L Nanayakkara, Brij Madhok, et al.Pageof 12